IBKS No3 SPAC (225430) - Total Liabilities
Based on the latest financial reports, IBKS No3 SPAC (225430) has total liabilities worth ₩21.04 Billion KRW (≈ $14.26 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 225430 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
IBKS No3 SPAC - Total Liabilities Trend (2015–2025)
This chart illustrates how IBKS No3 SPAC's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 225430 total assets.
IBKS No3 SPAC Competitors by Total Liabilities
The table below lists competitors of IBKS No3 SPAC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Oculus VisionTech Inc
V:OVT
|
Canada | CA$829.23K |
|
Pheton Holdings Ltd Class A Ordinary Shares
NASDAQ:PTHL
|
USA | $382.60K |
|
Siti Networks Limited
NSE:SITINET
|
India | Rs24.61 Billion |
|
Ankit Metal & Power Limited
NSE:ANKITMETAL
|
India | Rs10.32 Billion |
|
International Prospect Ventures Ltd
V:IZZ
|
Canada | CA$240.93K |
|
QMC Quantum Minerals Corp
V:QMC
|
Canada | CA$3.70 Million |
|
Greenwave Technology Solutions Inc. Common Stock
NASDAQ:GWAV
|
USA | $31.56 Million |
|
Constellation Technologies Ltd
AU:CT1
|
Australia | AU$793.97K |
Liability Composition Analysis (2015–2025)
This chart breaks down IBKS No3 SPAC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 225430 net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.79 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IBKS No3 SPAC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IBKS No3 SPAC (2015–2025)
The table below shows the annual total liabilities of IBKS No3 SPAC from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩18.13 Billion ≈ $12.28 Million |
+10.81% |
| 2024-12-31 | ₩16.36 Billion ≈ $11.09 Million |
+8.50% |
| 2023-12-31 | ₩15.08 Billion ≈ $10.22 Million |
+0.83% |
| 2022-12-31 | ₩14.95 Billion ≈ $10.13 Million |
+17.10% |
| 2021-12-31 | ₩12.77 Billion ≈ $8.65 Million |
+34.90% |
| 2020-12-31 | ₩9.47 Billion ≈ $6.42 Million |
-50.04% |
| 2019-12-31 | ₩18.95 Billion ≈ $12.84 Million |
+112.86% |
| 2018-12-31 | ₩8.90 Billion ≈ $6.03 Million |
+497.00% |
| 2017-12-31 | ₩1.49 Billion ≈ $1.01 Million |
+2.33% |
| 2016-12-31 | ₩1.46 Billion ≈ $987.52K |
+2.42% |
| 2015-12-31 | ₩1.42 Billion ≈ $964.22K |
-- |
About IBKS No3 SPAC
KMPHARMACEUTICAL Co.,Ltd. engages in the manufacture, wholesale, and retail of oral care, beauty care, and other daily necessities in South Korea and internationally. The company offers toothpastes, toothbrushes, cosmetics, masks, hand cream, toothbrush and toothpaste, kids toothbrush, and baby finger toothbrush sets. It also provides children's safety gargles, baby and light wipes, wet wipes, an… Read more